Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.33 USD
−21.72 M USD
159.01 M USD
41.50 M
About Axogen, Inc.
Sector
Industry
CEO
Michael D. Dale
Website
Headquarters
Alachua
Founded
1977
FIGI
BBG000BN46R9
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Potential double bottom.Just an idea, potential double bottom on .382 fib retracement.
Maybe descending triangle forming ?
Anchored VWAP from 07 low shows the lower deviation band has been an attractive buy in level.
Axogen, Inc. Announces Positive Topline Results from Phase 3AXGN: Axogen, Inc.
2022-05-04 16:01:00
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft
$AXGN can fall in the next daysContextual immersion trading strategy idea.
AxoGen provides surgical solutions for physical damage or transection to peripheral nerves.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price in the next days.
So I opened a
AXGN LongBeen watching AXGN for the past month. It has found a bottom @$14.50 and has begun to make higher highs. AXGN is currently UNDERVALUED and will quickly jump to $20.00 after breaking the $17.00 resistance.
AXGN - Trade setupThis stock is just getting crushed. If we break that pivot it's going lower, to the 100MA on the monthly chart.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AXGN is 16.26 USD — it has increased by 9.91% in the past 24 hours. Watch Axogen, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Axogen, Inc. stocks are traded under the ticker AXGN.
AXGN stock has risen by 21.57% compared to the previous week, the month change is a 30.33% rise, over the last year Axogen, Inc. has showed a 126.46% increase.
We've gathered analysts' opinions on Axogen, Inc. future price: according to them, AXGN price has a max estimate of 22.00 USD and a min estimate of 17.00 USD. Watch AXGN chart and read a more detailed Axogen, Inc. stock forecast: see what analysts think of Axogen, Inc. and suggest that you do with its stocks.
AXGN reached its all-time high on Jul 24, 2018 with the price of 56.85 USD, and its all-time low was 0.20 USD and was reached on Aug 20, 2002. View more price dynamics on AXGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AXGN stock is 6.57% volatile and has beta coefficient of 0.14. Track Axogen, Inc. stock price on the chart and check out the list of the most volatile stocks — is Axogen, Inc. there?
Today Axogen, Inc. has the market capitalization of 756.50 M, it has decreased by −0.81% over the last week.
Yes, you can track Axogen, Inc. financials in yearly and quarterly reports right on TradingView.
Axogen, Inc. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AXGN earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.01 USD resulting in a 1.07 K% surprise. The estimated earnings for the next quarter are 0.03 USD per share. See more details about Axogen, Inc. earnings.
Axogen, Inc. revenue for the last quarter amounts to 48.64 M USD, despite the estimated figure of 47.07 M USD. In the next quarter, revenue is expected to reach 47.57 M USD.
AXGN net income for the last quarter is −1.86 M USD, while the quarter before that showed −1.92 M USD of net income which accounts for 3.28% change. Track more Axogen, Inc. financial stats to get the full picture.
No, AXGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 428.00 employees. See our rating of the largest employees — is Axogen, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axogen, Inc. EBITDA is −723.00 K USD, and current EBITDA margin is −10.00%. See more stats in Axogen, Inc. financial statements.
Like other stocks, AXGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axogen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Axogen, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Axogen, Inc. stock shows the buy signal. See more of Axogen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.